Advanced Hemodynamic Monitoring Allows Recognition of Early Response Patterns to Diuresis in Congestive Heart Failure Patients.
congestive heart failure
digital health
diuresis
personalized medicine
remote patient monitoring
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 Dec 2022
21 Dec 2022
Historique:
received:
09
10
2022
revised:
16
12
2022
accepted:
19
12
2022
entrez:
8
1
2023
pubmed:
9
1
2023
medline:
9
1
2023
Statut:
epublish
Résumé
There are no clear guidelines for diuretic administration in heart failure (HF), and reliable markers are needed to tailor treatment. Continuous monitoring of multiple advanced physiological parameters during diuresis may allow better differentiation of patients into subgroups according to their responses. In this study, 29 HF patients were monitored during outpatient intravenous diuresis, using a noninvasive wearable multi-parameter monitor. Analysis of changes in these parameters during the course of diuresis aimed to recognize subgroups with different response patterns. Parameters did not change significantly, however, subgroup analysis of the last quartile of treatment showed significant differences in cardiac output, cardiac index, stroke volume, pulse rate, and systemic vascular resistance according to gender, and in systolic blood pressure according to habitus. Changes in the last quartile could be differentiated using k-means, a technique of unsupervised machine learning. Moreover, patients' responses could be best clustered into four groups. Analysis of baseline parameters showed that two of the clusters differed by baseline parameters, body mass index, and diabetes status. To conclude, we show that physiological changes during diuresis in HF patients can be categorized into subgroups sharing similar response trends, making noninvasive monitoring a potential key to personalized treatment in HF.
Identifiants
pubmed: 36614848
pii: jcm12010045
doi: 10.3390/jcm12010045
pmc: PMC9821287
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Sci Rep. 2020 Oct 19;10(1):17684
pubmed: 33077774
JAMA. 2005 Oct 5;294(13):1625-33
pubmed: 16204662
Br Heart J. 1994 Aug;72(2 Suppl):S44-7
pubmed: 7946758
Cardiology. 1994;84 Suppl 2:115-23
pubmed: 7954533
N Engl J Med. 1997 Nov 6;337(19):1360-9
pubmed: 9358131
J Cardiovasc Med (Hagerstown). 2020 Jan;21(1):21-26
pubmed: 31714331
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD003825
pubmed: 22895937
Eur J Heart Fail. 2005 Oct;7(6):953-7
pubmed: 16227134
Card Fail Rev. 2017 Nov;3(2):108-112
pubmed: 29387462
Diab Vasc Dis Res. 2013 Jul;10(4):330-6
pubmed: 23349368
J Am Coll Cardiol. 2013 Jan 29;61(4):391-403
pubmed: 23219302
J Am Coll Cardiol. 2007 Apr 3;49(13):1450-8
pubmed: 17397674
J Card Fail. 2015 Jun;21(6):479-88
pubmed: 25921522
Am J Med. 1981 Feb;70(2):234-9
pubmed: 7468610
Circulation. 1997 Sep 16;96(6):1847-52
pubmed: 9323071
Ann Intern Med. 1985 Jul;103(1):1-6
pubmed: 2860833
Cardiol Rev. 2000 Mar-Apr;8(2):104-14
pubmed: 11174882
N Engl J Med. 1973 May 24;288(21):1087-90
pubmed: 4697939
Curr Cardiol Rep. 2015 Dec;17(12):113
pubmed: 26482756
Womens Health (Lond). 2009 Sep;5(5):517-27
pubmed: 19702451
J Card Fail. 2012 Nov;18(11):837-44
pubmed: 23141856
Eur J Heart Fail. 2009 Apr;11(4):420-7
pubmed: 19252210
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Circulation. 2020 Feb 4;141(5):338-351
pubmed: 31736337
Pharmacology. 2004 Feb;70(2):107-12
pubmed: 14685014
ESC Heart Fail. 2014 Sep;1(1):4-25
pubmed: 28834669
Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):68-75
pubmed: 21139091